- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02874443
The REDUCED Trial: REDucing the Utilization of CEsarean Sections for Dystocia (REDUCED)
April 19, 2024 updated by: Stephen Wood, University of Calgary
This project is a clustered randomized controlled trial of a knowledge translation intervention of new ACOG guidelines for the diagnosis of poor progress in labor.
The intent is to reduce the rate of cesarean section (CS) in first time mothers at term (>= 37 weeks), with a vertex presenting singleton fetus, without increasing maternal or neonatal morbidity.
The guidelines were developed from data from the Consortium for Safe Labor.
The unit of randomization will be sites in Alberta that deliver
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Cluster randomized controlled trial of a knowledge translation intervention of new guidelines for the diagnosis of poor progress in labor.
The intervention will be randomized to centres (the clusters) in Alberta that provide intrapartum care, have facilities to perform cesarean section and deliver at least 70 primparous women annually, with stratification based on facility type and geographic location.
Clustering by centre and not individual caregivers (nurses/physicians) is necessary to prevent leakage or crossover of the intervention to controls.
As all participating centres will eventually receive the intervention, the biostatistician will generate a randomization into two "waves".
The intervention will be introduced sequentially by strata (Calgary, Edmonton, regional centres, rural centres) to the first "wave" hospitals in multi-week run-in periods after which those strata will be revisited for roll-out to the second "wave" hospitals.
Study Type
Interventional
Enrollment (Estimated)
100000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Janice Skiffington, MSc
- Phone Number: 403-944-8446
- Email: janice.skiffington@ahs.ca
Study Contact Backup
- Name: Stephen Wood, MD MSc
- Phone Number: 403-9441438
- Email: slwood@ucalgary.ca
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 2T9
- Recruiting
- University of Calgary
-
Contact:
- Stephen Wood, MD
- Phone Number: 403-944-1438
- Email: slwood@ucalgary.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Centers in Alberta that provide intrapartum care, have facilities to perform cesarean section and deliver at least 70 primparous women annually
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention centers
Application of a knowledge translation strategy, of new clinical practice guidelines on labor management, to physicians and nurses caring for women in labor. Intervention centers will receive knowledge translation of labor management guidelines |
|
No Intervention: Control centers
No intervention at control centers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Cesarean section
Time Frame: at delivery
|
Rate of Cesarean section in primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
at delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of perinatal death
Time Frame: at delivery
|
Rate of perinatal death for primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
at delivery
|
Rate of neonatal asphyxia
Time Frame: at delivery
|
Neonatal asphyxia is defined as intrapartum stillbirth or neonatal death from asphyxia (Perinatal Society of Australia and New Zealand coding) or Neonatal Intensive Care Unit admission and at least two of: a. Apgar score of ≤5 at 10 minutes; b.
Mechanical ventilation or chest compressions for resuscitation within 10 minutes; c.
Cord pH < 7.00 (venous or arterial), or arterial base excess ≥ 12 at birth.
Rate of neonatal asphyxia for deliveries involving primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
at delivery
|
Rate of moderate or severe asphyxia or meets criteria for therapeutic cooling
Time Frame: at delivery
|
Rate of moderate or severe asphyxia or meets criteria for therapeutic cooling for deliveries involving primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
at delivery
|
Rate of neonatal sepsis or suspected sepsis
Time Frame: at delivery
|
Rate of neonatal sepsis or suspected sepsis for deliveries involving primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
at delivery
|
Rate of post partum hemorrhage
Time Frame: at delivery
|
Rate of post partum hemorrhage for primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
at delivery
|
Rate of blood transfusion
Time Frame: at delivery
|
Rate of blood transfusion for primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
at delivery
|
Rate of postpartum uterine artery/pelvic artery embolization
Time Frame: Within 30 days of delivery
|
Rate of postpartum uterine artery/pelvic artery embolization for primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
Within 30 days of delivery
|
Rate of postpartum hysterectomy
Time Frame: Within 30 days of delivery
|
Rate of postpartum hysterectomy for primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
Within 30 days of delivery
|
Rate of postpartum maternal intensive care unit (ICU) admission
Time Frame: at delivery
|
Rate of postpartum maternal intensive care unit (ICU) admission for primiparous women in labor, at term (>= 37 weeks), with a vertex presenting singleton fetus
|
at delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephen Wood, MD MSc, University of Calgary
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Estimated)
February 28, 2025
Study Completion (Estimated)
March 30, 2025
Study Registration Dates
First Submitted
August 17, 2016
First Submitted That Met QC Criteria
August 19, 2016
First Posted (Estimated)
August 22, 2016
Study Record Updates
Last Update Posted (Estimated)
April 23, 2024
Last Update Submitted That Met QC Criteria
April 19, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB16-1576
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section, Dystocia
-
Christiana Care Health ServicesCompletedLabor Long | Cesarean Section, Affecting Fetus or Newborn | Dystocia; FetalUnited States
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Atatürk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Virginia Commonwealth UniversityRecruitingCesarean SectionUnited States
-
University Tunis El ManarCompleted
-
Federico II UniversityCompletedCesarean SectionItaly
-
Virginia Commonwealth UniversityCompletedCesarean SectionUnited States
-
University of CalgaryCompleted
Clinical Trials on Knowledge Translation of labor management guidelines
-
Ottawa Hospital Research InstituteQueensway Carleton HospitalActive, not recruiting
-
Ottawa Hospital Research InstituteRecruiting
-
University of ArizonaCompletedTBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Injuries, Acute BrainUnited States
-
Hospices Civils de LyonCompleted
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
Christiana Care Health ServicesCompleted
-
Federal University of Minas GeraisUnknownType 2 Diabetes MellitusBrazil
-
Hanoi Medical UniversityCompleted
-
University of NottinghamUniversity of BeninUnknown